NCT03637101View on ClinicalTrials.gov

Ischemia Modified Albumin in Traumatic Brain Injury

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

December 7, 2018

Study Completion Date

December 7, 2018

Conditions
Traumatic Brain Injury
Interventions
DIAGNOSTIC_TEST

Ischemia modified albumin (IMA)

Ischemia modified albumin is a biomarker for cardiac ischemia and acute stroke whether ischemic or hemorrhagic

Trial Locations (1)

11562

Kasr El Aini Hospital, Cairo

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER

NCT03637101 - Ischemia Modified Albumin in Traumatic Brain Injury | Biotech Hunter | Biotech Hunter